author-photo

Matteo Menotti

University of Turin

12

Papers

172

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma

2019 Nature Medicine
Show All
- Source
- Cite
- Save
Citations (31)
Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1

2016 Oncotarget
Show All
- Source
- Cite
- Save
Citations (23)
Redundant and nonredundant roles for Cdc42 and Rac1 in lymphomas developed in NPM-ALK transgenic mice.

2016 Blood
Show All
- Source
- Cite
- Save
Citations (20)
Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency

2016 Oncogene
Show All
- Source
- Cite
- Save
Citations (30)
Abstract 131: ALK oncogene regulates epithelial-mesenchymal transition (EMT) in ALK-rearranged non-small cell lung carcinoma through repression of the epithelial splicing regulatory proteins 1 and 2 (ESRP1 and ESRP2)

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 2920: Excess of cytoplasmic NPM-ALK driven oncogenic signaling is toxic and promotes cellular apoptosis and drug dependency

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors

2015 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (24)
ALK-Dependent Control of Hypoxia-Inducible Factors Mediates Tumor Growth and Metastasis

2014 Cancer Research
Show All
- Source
- Cite
- Save
Citations (34)
874 ALK Inhibitors and Vaccination Against Anaplastic Lymphoma Kinase (ALK) Induce Potent Anti-tumor Activity Improving Overall Survival in Non Small Cell Lung Carcinoma (NSCLC)

2012 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
1007 ORAL Efficacy of DNA Vaccination Against Anaplastic Lymphoma Kinase (ALK) in Non Small Cell Lung Carcinoma (NSCLC)

2011 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)